Product Images Desvenlafaxine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Desvenlafaxine NDC 50090-7737 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - desvenlafaxine tablets figure 1

image description - desvenlafaxine tablets figure 1

image description - desvenlafaxine tablets figure 2

image description - desvenlafaxine tablets figure 2

This is a comparison of the change in Cmax levels of Ketoconazole due to PK with CYP3A4 inhibitors. The geometric mean ratios with 90% confidence intervals are provided for the change relative to the reference values. For Ketoconazole Cmax, the values are 1.08 (1.00-1.17) and 1.43 (1.38-1.49).*

image description - desvenlafaxine tablets figure 3

image description - desvenlafaxine tablets figure 3

image description - desvenlafaxine tablets figure 4

image description - desvenlafaxine tablets figure 4

This is a chart showing the estimated proportion of patients with relapse over time to relapse in days from randomization for a treatment with Desverla 50mg compared to a placebo. The chart indicates that by day 200, around 40% of patients on Desverla 50mg and 0% of patients on placebo had experienced a relapse.*

image description - desvenlafaxine tablets figure 5

image description - desvenlafaxine tablets figure 5

image description - desvenlafaxine tablets structure

image description - desvenlafaxine tablets structure

Label Image - lbl500907737

Label Image - lbl500907737

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.